UBE2F and ovarian carcinoma: Importantly, besides lung cancer cells, multiple cancer cells, including ovarian cancer cells and breast cancer cells, all could upregulate the expression of UBE2F responding to platinum treatments, suggesting UBE2F may be a potentially universal drug target of platinum-sensitization.